Pathophysiology of ANCA-associated vasculitis: are ANCA really pathogenic? A note of caution - Reply: are ANCA really pathogenic?Tervaert, JWC. & Heeringa, P., Dec-2003, In : The Netherlands Journal of Medicine. 61, 12, p. 404-407 4 p.
Research output: Contribution to journal › Review article › Academic › peer-review
The strong relation between antineutrophil cytoplasmic autoantibodies (ANCA) and primary vasculitic syndromes suggests a pathophysiological role for ANCA.
Experimental evidence for the pathogenic potential of ANCA has been derived from in vitro studies that demonstrate that ANCA can activate tumour necrosis factor alpha primed neutrophils, monocytes and/or endothelial cells. The binding of ANCA to primed neutrophils results in activation of these cells by a process that is largely dependent on engagement of beta-2 integrins and on the interaction of the Fc portion of ANCA. An Fc-independent mechanism is, however, also operative. In experimental animal models, it has been demonstrated that immunisation with myeloperoxidase (MPO) induces MPO-ANCA. The induction of ANCA, however, is not sufficient to induce vasculitis in rats since immune complexes first have to be deposited along the vessel wall before lesions develop. When MPO-deficient mice are, however, immunised with murine MPO, anti-MPO immunoglobulins are purified and subsequently injected into mice that are not deficient for MPO, systemic vasculitis and glomerulonephritis is induced. These experiments suggest that ANCA indeed induces vasculitis. Risk factors for breaking self-tolerance to ANCA antigens are genetic factors, drugs, chemical substances and/or infectious agents.
|Number of pages||4|
|Journal||The Netherlands Journal of Medicine|
|Publication status||Published - Dec-2003|
- ANTINEUTROPHIL CYTOPLASMIC AUTOANTIBODIES, HUMAN ENDOTHELIAL-CELLS, WEGENERS-GRANULOMATOSIS, ANTIMYELOPEROXIDASE ANTIBODIES, SYSTEMIC VASCULITIS, UP-REGULATION, IN-VITRO, AUTOIMMUNE VASCULITIS, HUMAN NEUTROPHILS, MYELOPEROXIDASE